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Background and Aims: Interventional pulmonology is a rapid evolutional area in pulmonary medicine. Flexi-rigid pleuroscopy is performed on patient with local anaesthesia under the aid of conscious sedation. Pleuroscopy is a safe procedure with estimated mortality rate around 0.09-0.34%.
Methods:
A 29 year-old female presented to our clinic for her right recurrent effusion. She was diagnosed as tuberculosis (TB) 2 years ago with complete treatment. For fear of TB resistance, she was advised to have pleural biopsy for tissue TB culture. Also, chest computed tomography (CT) showed both pleural effusion and ascites. The chest CT did not suggest intrapulmonary lesions. When performing pleuroscopy, there was no lesions such as fibrinous adhesion nor organized fibrin as seen in pleural TB. The effusion revealed exudative in character. Patient then received a series of study including CA125 and gynaecological sonography. Patient then received uterine myomectomy intervention.
Results:
The pleuroscopy biopsy did not suggest TB infection. The pleural effusion showed exudative in character. The sonographic study revealed a huge uterine mass (more than 10 cm) with high CA125, 510 U/mL. The effusion resolved after uterine myomectomy. She then was diagnosed as pseudo-Meigs' syndrome.
Conclusion: Pseudo Meigs' syndrome is not common at all. It represents a triad of pleural effusion, ascites, and a gynaecologic tumor except ovarian tumor. The tumor is usually benign. By definition, it lacks of evidence for tumor spreading in peritoneal or pleural cavities (negative pleural and peritoneal fluid cytology and/or no malignant involvement in biopsy samples) and both of ascites and hydrothorax must resolve after tumor removal. Background and Aims: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is recommended not only for differential diagnosis but also for lymph node staging. Although 22 gauge needles have been widely used, some stations are often difficult to puncture due to its acute angle (e.g. #2R/L, #3p, #4L, and so on). Meanwhile, a smaller 25 gauge needle has been introduced in Japan at the end of 2016. This needle offers a structural advantage of better flexibility and puncturability. We aimed to validate the clinical impact of this new needle in lymph node staging.
Methods: This is a Cohort designed study enrolling consecutive patients who underwent EBUS-TBNA for lymph node staging using the 25 gauge needle at National Cancer Center Hospital from September 2016 to March 2018. Patients with confirmed stage IV disease were excluded. The following information were collected and analyzed: punctured lesions, sampling rates, results of the staging and the pathology, complications, and treatment policies.
Results: Of the 70 eligible patients, 315 punctures were made from 182 lesions (#2R: 20, #2L: 3, #3P: 4, #4R: 45, #4L: 28, #7: 35, #10R: 2, #10L: 4, #11s: 12, #11i: 6, #11L: 19, #12L: 4); by which 277 core tissues were sampled (the sampling rate was 87.9%). All of the lymph node staging were successfully performed without any severe complications; The results were: N0: 15, N1: 10, N2: 26, N3: 19, respectively. Clinical decisions for patients, except two, were determined according to the staging (Figure) . On the other hand, 20 cases (38 lymph nodes) had to be verified pathologically by surgical resection. The overall sensitivity, specificity, pos-
